Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
147
147 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CHF10196florensocatibPhase 31 trial
Chiesi Farmaceutici S.p.A. · Bronchiectasis
- HR-1703Phase 31 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma With Eosinophilic Phenotype
- JKN2401Phase 31 trial
Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)
- QMF149Phase 31 trial
Novartis · Asthma
- QVM149Phase 31 trial
Novartis · Asthma
- SC1011Phase 31 trial
Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis
- TEV-56248Phase 31 trial
Teva · Asthma
- AK139Phase 26 trials
Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria
- VerekitugUPB-101Phase 24 trials
Upstream Bio Inc. · Severe Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps
- ENV-294Phase 23 trials
Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma
- GalvokimigUCB9741Phase 23 trials
UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis
- KT-621Phase 23 trials
Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)
- VapendavirVPV, VapendaivrPhase 23 trials
Altesa Biosciences, Inc. · Rhinovirus Infection, COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection
- 9MW1911Phase 22 trials
Mabwell (Shanghai) Bioscience Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease COPD
- AD17002LThPhase 22 trials
Advagene Biopharma Co. Ltd. · Eosinophilic Asthma
- ARO-RAGEPhase 22 trials
Arrowhead Pharmaceuticals · Asthma
- AZD0292Phase 22 trials
AstraZeneca · Bronchiectasis With Pseudomonas Aeruginosa Colonization
- FB825Phase 22 trials
Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis
- GSK3862995BPhase 22 trials
GSK · Bronchiectasis, Pulmonary Disease, Chronic Obstructive
- HB0056Phase 22 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)
- HS235Phase 22 trials
35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
- IfetrobanPhase 22 trials
Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited
- JNJ-95597528Phase 22 trials
Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma
- LASN01Phase 22 trials
Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy
- LondamocitinibAZD4604Phase 22 trials
AstraZeneca · Asthma
- NS-863Phase 22 trials
NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension
- PA9159 Metered-DosePhase 22 trials
Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma
- per day for 28 daysPhase 22 trials
Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma
- PRA-216Phase 22 trials
Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma
- RC1416Phase 22 trials
Nanjing RegeneCore Biotech Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe Asthma
- SolrikitugPhase 22 trials
Uniquity One (UNI) · Eosinophilic Esophagitis (EoE), COPD
- TQC2938Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Seasonal Allergic Rhinitis
- TTI-101Phase 22 trials
Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis
- WIN378Phase 22 trials
Windward Bio · COPD (Chronic Obstructive Pulmonary Disease), Asthma
- XKH001InjectionXKH001Phase 22 trials
Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis
- ABBV-142Phase 21 trial
AbbVie · Idiopathic Pulmonary Fibrosis
- AGMB-447Phase 21 trial
Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)
- ANG003Phase 21 trial
Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
- AP02Phase 21 trial
Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)
- APL-9796Phase 21 trial
Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension
- ARCT-032Phase 21 trial
Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation
- AZD6793Phase 21 trial
AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD)
- AZD8630Phase 21 trial
AstraZeneca · Asthma
- AZD8965Phase 21 trial
AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)
- BBT-877Phase 21 trial
Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis
- BC006Phase 21 trial
Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)
- BI 1819479Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 3810477Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 765423Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial
BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.